Amy W. Schulman, Director, 10% Owner at SQZ Biotechnologies Co (SQZ), bought 525,860 shares at $16.00 ($4.0M) on 2020-11-03, disclosed to the SEC on 2020-11-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 275,860 | $0 | 0.0% |
| 2 | $16.00 | 16,346 | $262K | 6.5% |
| 3 | $16.00 | 233,654 | $3.7M | 93.5% |
| Total | $7.61 avg | 525,860 | $4.0M | 100% |
| Filing → |
| ALNY | SELL | 2024-06-27 | $2.0M | — | Filing → |
| ALNY | SELL | 2024-05-31 | $6.4M | — | Filing → |
| SQZ | BUY | 2021-12-15 | $40K | — | Filing → |